Cost-Effectiveness Analysis of Serum Free Light Chain Assay (FREELITE®) for The Diagnosis of Monoclonal Gammopathy in The Brazilian Public and Private Healthcare Systems
Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.2009
https://www.valueinhealthjournal.com/article/S1098-3015(16)33375-7/fulltext
Title :
Cost-Effectiveness Analysis of Serum Free Light Chain Assay (FREELITE®) for The Diagnosis of Monoclonal Gammopathy in The Brazilian Public and Private Healthcare Systems
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)33375-7&doi=10.1016/j.jval.2016.09.2009
First page :
A696
Section Title :
Health Care Treatment Studies
Open access? :
No
Section Order :
1902